KUP-101A

N/A

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameKUP-101A
Drug Alias NameKUP-101A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSkin MelanomaCarcinoma, BasosquamousCarcinoma, Basal Cell +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKupando GmbH
China Registration ClassN/A

Develop Information

Active CompaniesKupando GmbH
Inactive CompaniesN/A
Active IndicationsSkin MelanomaCarcinoma, BasosquamousCarcinoma, Basal Cell +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A